Colgate-Palmolive (CL) Vice Chairman Sells $10,021,398.11 in Stock

Colgate-Palmolive (NYSE:CL) Vice Chairman Franck Moison sold 142,979 shares of the business’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the transaction, the insider now owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Colgate-Palmolive (NYSE CL) opened at $69.76 on Monday. Colgate-Palmolive has a 1-year low of $66.47 and a 1-year high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. The company has a market cap of $61,256.62, a PE ratio of 30.60, a PEG ratio of 2.58 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the prior year, the company earned $0.75 earnings per share. The business’s revenue was up 4.6% compared to the same quarter last year. sell-side analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 annualized dividend and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.

Several equities analysts have issued reports on the stock. Citigroup upped their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Tuesday, January 30th. BNP Paribas downgraded shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Jefferies Group restated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 26th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Tuesday, January 16th. Finally, Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $77.71.

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Jacobi Capital Management LLC raised its holdings in Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Krilogy Financial LLC raised its holdings in Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new position in Colgate-Palmolive during the second quarter worth about $122,000. AlphaMark Advisors LLC raised its holdings in Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC purchased a new position in Colgate-Palmolive during the second quarter worth about $126,000. 72.85% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive (CL) Vice Chairman Sells $10,021,398.11 in Stock” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.americanbankingnews.com/2018/02/07/colgate-palmolive-cl-vice-chairman-sells-10021398-11-in-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply